THURSDAY | JUNE 11, 2020

Visit  www.asippannualmeeting.com  for more details. We will update this site frequently with new information as it becomes available. 

Visit this site for information on our refund policy. 
ASIPP WEBINAR-BASED VIRTUAL EDUCATION
Registration Open
Online education is the most convenient way to educate yourself and obtain your
required CMEs from the comfort of your home or office. ASIPP® is offering a series
of online courses to learn and earn CMEs.

Documentation, Coding, Compliance, and Practice Management
is the first course. We hope you'll register after you look over the schedule .

The speakers and topics are the best.


Virtual learning is the easiest way to learn and to earn Credit hours.
Now you don't have to leave the house or office to earn required CMEs.

ASIPP® is offering a series of virtual courses like Controlled Substance Management
We hope you'll register after you look over the schedule .

The speakers and topics are the best.



Additional Course


(Note* This course takes place over two weekends (Friday evening through Sunday) in order to fulfill the necessary topics)

May/June 2020 Issue Available
In this issue, Pain Physician includes randomized trials on cervical plexus blocks for endarterectomy, pulsed radiofrequency for hemiplegic shouldr pain, ultrasound-guided injection for meralgia paresthetica, and more.
Randomized Trial
Emiliano Petrucci, MD, Vincenza Cofini, MD, Barbara Pizzi, MD, Rosaria Coletta, MD, Angelo Geremia Blasetti, MD, Stefano Necozione, MD, Pierfrancesco Fusco, MD, and Franco Marinangeli, MD.
Randomized Trial
Ebru Alanbay, MD, Berke Aras, MD, Serdar Kesikburun, MD, Selvinaz Kizilirmak, MD, Evren Yasar, MD, and Arif Kenan Tan, MD.

Randomized Trial
Selda Kiliç, MD, Feyza Ünlü Özkan, MD, Duygu Geler Külcü, MD, Gülcan Öztürk, MD, Pinar Akpinar, MD, and Ilknur Aktas, MD.

Randomized Trial
Botao Liu, MD, Yang Yang, MD, Zhongyi Zhang, MD, Haining Wang, MD, Bifa Fan, MD, and Lei Sima, MD.


FULL ARTICLE PDFs | painphysicianjournal.com
 Waivers Related to COVID-19 Effective Date
 

Based on the information from multiple CMS officials, all the waivers related to COVID-19 including telehealth waivers will be effective through the end of the emergency declaration.
 
Essentially, emergency declaration is a continuous phenomenon as of now and we are not aware of when it will end. Thus, we believe that all waivers, including telehealth services and phone-only services, which have been retroactive to March 1, 2020, will be effective through the end of the emergency declaration.
 
This applies only to Medicare, however, we continue to work to gain coverage from other insurers as well. 
 
 

VIEW ARCHIVED WEBINARS
 
 
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 6
 
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 5
 
ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 4

ASIPP COVID-19 FOR INTERVENTIONAL PAIN PHYSICIANS WEBINAR SERIES – PART 3
 
Surviving the COVID-19 Epidemic: Protecting Family and Employees and Managing Financial Issues and Burnout – PART 2

Surviving the Coronavirus Pandemic: Practical Advice Every Pain Physician Needs to Know – PART 1
Vertebral Augmentation Proposed LCD Announced


We are following up on the LCDs for vertebral augmentation. Medicare Administrators are now releasing their proposed LCDs on this procedure. 
 
Please find the Proposed LCD that we received today from CGS. This policy will be presented at an open meeting on June 23, 2020. The deadline requests to present at the meeting is June 8, 2020.
 
Currently, we do not see any issues that require further comments, however if you feel you want to comment or make a presentation, please feel free to do so. The LCD provided is only applicable to CGS (Kentucky and Ohio).

If you are in a different state, please look at the CMS Website for your Administrator. We will continue to update you as we gain more information

ABIPP Recognizes Your Knowledge and Expertise
 
The  American Board of Interventional Pain Physicians  ( ABIPP )  has developed certification programs that recognize accepted levels of knowledge and expertise in the interventional pain management profession, with the goal of improved patient care. Hundreds of qualified physicians have made the commitment to become  ABIPP  certified.
 
ABIPP  now offers the only competency   certification program for regenerative medicine.
DATES

ABIPP Part I  - Theoretical written exam - October 3

ABIPP Part II   - Oral and Hands-on practical exam - October 3-4

ABIPP Competency Exam  - includes written, oral, and hands-on practical examinations October 3-4

Combined CSM/CCPM Exam for ABIPP Path   – October 3

Competency Exam in Controlled Substance Management – October 3

Competency Exam in Coding, Compliance, and Practice Management - October 3

Regenerative Medicine Competency Exam  - includes written, oral, and hands-on practical examinations – October 3-4
For complete information about the examination requirements and to obtain an application packet, visit www.abipp.org  or call 270-554-9412 x4217 or by email at   summer@asipp.org .
Protests Pose Particular Risks for COVID-19 Transmission
Nationwide protests about racial injustice in the U.S. not only ignited a political powder keg, but could also be sparking increases in COVID-19 transmission just as the country was hoping to see it diminish.

Thousands of protesters have been depicted not social distancing from one another, and some not wearing masks in public. Experts told MedPage Today that viral transmission risks at these events go far beyond these non-pharmaceutical interventions. (See a  separate MedPage Today report  on concerns over a potential COVID-19 surge in Minneapolis related to protests there.)
READ MORE | MEDPAGE TODAY |

Revenue Drying Up for Clinics Shuttered by COVID-19
When Todd J. Maltese, DO,  shut down his neurology clinic in March,  he estimated revenue generated through telemedicine appointments would be enough to last him 3 months.
It wasn't.

"The income coming in from telemedicine would not have been enough," Maltese told MedPage Today. "The only way I survived was with the loans and grants."

Maltese, who co-runs a neurology and sleep medicine clinic on Long Island in New York, reopened his practice May 18 and is currently running at about 50% capacity. While his practice transitioned to telemedicine rather smoothly, he primarily sees headache patients, many of whom require injections that, along with other procedures, account for the majority of the clinic's revenue.
READ MORE | MEDPAGE TODAY |
CDC: Coronavirus Antibody Tests Still Not Accurate Enough
HealthDay News — Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work, schools, dormitories, correctional facilities, and other locations, the U.S. Centers for Disease Control and Prevention said Wednesday.

The agency also said too little is known about what the presence of antibodies means in terms of a person’s future immunity,  CBS News  reported.

Widespread, accurate antibody testing could help track the spread of the new coronavirus and the actual death rate from  COVID-19 , but the CDC said research on antibodies produced in response to the new coronavirus is still ongoing and people who test positive for the antibodies should not assume they have immunity against the new coronavirus,  CBS News  reported.
READ MORE | CLINICAL PAIN ADVISOR |

Five-Day Course of Remdesivir Beneficial in Severe COVID-19
HealthDay News – There seems to be no significant difference between a 5- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation, according to a study published online May 27 in the  New England Journal of Medicine .

Jason D. Goldman, MD, MPH, from the University of Washington in Seattle, and colleagues conducted a randomized phase 3 trial involving hospitalized patients with confirmed severe acute respiratory coronavirus 2 infection, oxygen saturation of 94% or less, and radiologic evidence of pneumonia. A total of 397 patients were randomly assigned to receive remdesivir for either 5 or 10 days (200 and 197, respectively).
READ MORE | MPR |
COVID-19 Monitoring and Response Among U.S. Air Force Basic Military Trainees — Texas, March–April 2020
Summary
What is already known about this topic?
Substantial COVID-19 transmission has been documented in some congregate living settings.

What is added by this report?
Nonpharmaceutical interventions (NPI) introduced among 10,579 basic trainees at Joint Base San Antonio-Lackland limited COVID-19 incidence to five cases (47 per 100,000 persons), three of which were in persons who were contacts of the first patient.

What are the implications for public health practice?
Despite documented outbreaks of COVID-19 in congregate settings, implementation of NPIs, including screening, testing, administrative measures, quarantine, isolation, and source control, can limit transmission of symptomatic COVID-19 and ensure continuity of critical activities.
Evidence for Limited Early Spread of COVID-19 Within the United States, January–February 2020

Summary
What is already known about this topic?
The first U.S. cases of nontravel–related COVID-19 were confirmed on February 26 and 28, 2020, suggesting that community transmission was occurring by late February.

What is added by the report?
Four separate lines of evidence (syndromic surveillance, virus surveillance, phylogenetic analysis, and retrospectively identified cases) suggest that limited U.S. community transmission likely began in late January or early February 2020, after a single importation from China, followed by multiple importations from Europe. Until late February, COVID-19 incidence was too low to be detected by emergency department syndromic surveillance for COVID-19–like illness.

What are the implications for public health practice?
Enhanced syndromic and virus surveillance will be needed to monitor COVID-19 trends for the duration of the pandemic.
ASIPP ® Partners with Fedora Billing And Revenue Cycle
Management Company 
ASIPP is now able to offer unique benefits for revenue cycle management with billing, etc.

Fedora is a company known to many of our board members and others. ASIPP ® has reached an agreement with Fedora to provide exclusive discounts on billing or revenue cycle management that will decrease practice costs and promote growth, or at least stop deterioration. It is not just a billing company; they streamline the billing and receivable process and constantly update payor regulations keeping your practice up to on date on a daily basis. 

You may view the ASIPP ® billing program website at the following link:   https://www.asippbilling.com/  

Some of the ASIPP ® Billing Program highlights are below:
Up to 50% savings for ASIPP ® members for their billing or revenue cycle management for their offices and surgery centers:
 
  • Expertise in interventional pain management billing for all types of services
  • 99% Clearing House Rate
  • 95% First-Time Claim Passage
  • 23.4 Average Days in A/R
  • Eligibility and Benefits Verification 
  • Pre-Certification/Prior Authorization
  • Denials and A/R Management 
VIEW THE ASIPP ® BILLING PROGRAM | CLICK HERE |
Join The Group Purchasing Organization Today
ASIPP ® has formed a partnership with Henry Schein and PedsPal , a national GPO that has a successful history of negotiating better prices on medical supplies and creating value added services for the independent physician. Working with MedAssets, PedsPal provides excellent pricing on products like contrast media that alleviate some of the financial pressures you experience today. While the cost of contrast media has skyrocketed due to the single dose vial issue, because we have partnered with Henry Schein, this could enable you to purchase Omnipaque 240mg/50mL for slightly above $4.50.

It will be easy for  ASIPP ® members in good standing to enroll today and begin to realize the savings this partnership can bring. Members can join or see sample prices by going to   http://pedspal.org/asipp/default.html    

Click on “view our discounted supplier prices” (Username:ASIPPmember and Password: Save) or click on the words "join for free now" and begin saving today!
LEARN MORE ABOUT GROUP PURCHASING | CLICK HERE |
Fauci: Moderna’s Phase 3 Covid-19 Vaccine Trial Of 30,000 Individuals Will Begin In July
Dr. Anthony Fauci said the Phase 3 trial of Moderna’s experimental COVID-19 vaccine will begin in July and include study of 30,000 patients who will be as young as 18 and include elderly Americans as well.

In an interview Tuesday with the editor of JAMA, Fauci said the trial will include primarily U.S. sites, but also include international sites enrolling 30,000 individuals in a “randomized placebo” controlled trial of Moderna’s vaccine against the Coronavirus strain Covid-19. Moderna’s vaccine candidate is considered in the lead among several efforts by drug and vaccine makers in the battle against the deadly virus.

A phase 3 trial is considered the final stage before potential approval by the U.S. Food and Drug Administration, which would make it available for patients across the country. Moderna  last week said it began enrolling 600 healthy participants  in a phase 2 clinical trial testing mRNA-1273, the company’s vaccine against the virus that causes Covid-19.
READ MORE | FORBES |
Survey
ASIPP Members Asked to Respond to Survey

Survey of Practice Parameters of Physicians Trialing and Implanting Spinal Cord Stimulators

We are asking you to take part in an online research study being done by the pain department at Beth Israel Deaconess Medical Center. This study has qualified for exempt status by the Beth Israel Deaconess Medical Center Institutional Review Board. Your participation in this survey is strictly voluntary. Note that there are no foreseeable risks associated with this study. Data will be analyzed in aggregate form and no information will be collected that could personally identify you. Importantly, your privacy will be maintained in all published and written data. The data will be stored as required by journal and professional standards.

If you choose to be in the study, you will complete an online survey. This survey will help us learn more about the practice parameters of pain physicians who perform spinal cord stimulator trials or implants.
The survey will take about 5 minutes to complete.


READ MORE | CURE MD |
FDA Issues Emergency Use Authorization for Impella RP in COVID-19
The US Food and Drug Administration (FDA) issued an emergency use authorization for use of the Impella RP heart pump system in COVID-19 patients with right heart failure or decompensation, Abiomed announced today.
 
“Based on extrapolation of data from the approved indication and reported clinical experience, FDA has concluded that the Impella RP may be effective at providing temporary right ventricular support for the treatment of acute right heart failure or decompensation caused by COVID-19 complications, including PE [pulmonary embolism],” the letter notes.
 
It cites, for example, use of the temporary heart pump in a 59-year-old woman suffering from COVID-19 who went into right ventricular failure and became hypotensive after an acute PE was removed. After placement of the device, the patient experienced a “dramatic and immediate” improvement in arterial pressure and the device was removed on the fifth day, according to Amir Kaki, MD, and Ted Schreiber, MD, Ascension St. John Hospital, Detroit, whose review of the case has been posted online.
READ MORE | CUREMD |
Essentials of Regenerative Medicine in Interventional
Pain Management
Essentials of Regenerative Medicine in Interventional Pain Management is a book to bring concise, collective, and comprehensive information to interventional pain physicians practicing regenerative medicine in managing chronic pain. Regenerative medicine is an integral part of interventional pain management within the definitions of interventional pain management and interventional techniques.

Each chapter contains an introduction of the subject, historical context,pathophysiology, applicability of regenerative medicine with its evidence base, indications, anatomy, technical aspects, complications, and precautions for each topic when available and applicable. This comprehensive book consists of 35 chapters, more than 350 figures, and 50 tables.
| ORDER | Essentials of Regenerative Medicine in IPM
Pass your Pain Boards. Guaranteed!


We guarantee that you pass your pain examination or the next year is on us! Find out why 3000 pain physicians became board certified because of us.


PainExam also offers preparation for the ABIPP Pain Management Board Exam!  
In addition, PainExam has now collaborated with ASIPP and offer 2 new programs:
The Virtual Ultrasound Training Series starting Wednesday June 17, 2020 and the Regenerative Medicine for Spine Disease course
Control Your Waiting Room TV

Customized waiting room TV exclusively for ASIPP ® members. Create your own ad-free television broadcasts using our videos, custom informational slides and your own YouTube videos. Even add local weather reports, news and live messages.
GET YOUR OWN LOBBY TV CHANNEL | CLICK HERE FOR ASIPP-TV |
OH / KY ANNUAL MEETING 2020
SOCIETIES OF INTERVENTIIONAL PAIN PHYSICIAN
AUGUST 21-23 | WESTIN CINCINNATI
STATE SOCIETY MEETINGS
Send in your state society meeting news to Holly Long , hlong@asipp.org
ASIPP ® | Pain Physician Journal | Phone | Fax | Email
STAY CONNECTED